City

Bethesda (2)

Condition

Thoracic Sarcomas (2)

Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura (1)

Esophageal Cancer (1)

Lung Cancer (1)

Melanoma (1)

Mesolthelioma (1)

Sarcoma (1)

Thorasic Cancers (1)

Thymoma (1)

Overall Status

Terminated (2)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

National Cancer Institute (NCI) (2)

Collaborator

Intervention

celebrex (1)

celecoxib (1)

cyclophosphamide (1)

h1299 cell lysates (1)

iscomatrix adjuvant (1)

tumor cell vaccine (1)

Study Documents

Intervention Type

biological (2)

drug (2)

Funder Type

NIH (2)

Study Type

Interventional (2)

thoracic sarcomas

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura Trial run by the NCI

Terminated

Thoracic Sarcomas
+4 more

H1299 cell lysates
+3 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Dec 27, 2021

Mesolthelioma, Esophageal Cancer, Lung Cancer Trial run by the NCI (Celebrex, Tumor cell vaccine)

Terminated

Mesolthelioma
+4 more

Celebrex
Tumor cell vaccine

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Nov 30, 2019